Klaus Logo
klaus dexscreener
klaus dexscreener

Revolutionary Cancer Test in the UK!

The NHS is trialling a groundbreaking blood test that detects 12 common cancers with over 99% accuracy. This potent advance could shift cancer detection from invasive methods to a simple blood sample. Approximately 8,000 patients will join trials, promising earlier diagnoses and treatment. Developed via AI tech, it measures micro RNA to pinpoint cancer locations. If successful, the NHS could introduce this swift and affordable screening within two years, aided by £2.4 million in government funding.
Klaus on Ethereum